エピジェネティクス診断の世界市場2019

GlobalInfoResearchが発行した調査報告書（GIR9100310）

◆英語タイトル：Global Epigenetics Diagnostic Market 2019 by Company, Regions, Type and Application, Forecast to 2024
◆商品コード：GIR9100310
◆発行会社（リサーチ会社）：GlobalInfoResearch
◆発行日：2019年10月（※2024年版があります。お問い合わせください）
◆ページ数：103
◆レポート形式：英語 / PDF
◆納品方法：Eメール
◆調査対象地域：グローバル
◆産業分野：医療
◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,480 ⇒換算￥515,040	見積依頼/購入/質問フォーム
Multi User（10名様閲覧用）	USD5,220 ⇒換算￥772,560	見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）	USD6,960 ⇒換算￥1,030,080	見積依頼/購入/質問フォーム

★GlobalInfoResearchに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalInfoResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。

本調査レポートは、エピジェネティクス診断の世界市場について調べ、まとめました。種類別セグメントは、試薬、キット、機器、酵素、サービス等、用途別セグメントは、オンコログ、非腫瘍学等に区分しました。エピジェネティクス診断の世界市場概観、企業動向、企業別エピジェネティクス診断シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。
・エピジェネティクス診断の市場概観
・エピジェネティクス診断の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等）
・エピジェネティクス診断の企業別販売動向、市場シェア、市場集中度、競争動向
・エピジェネティクス診断の世界市場規模
・エピジェネティクス診断の北米市場分析（アメリカ、カナダ、メキシコ等）
・エピジェネティクス診断のアメリカ市場規模推移
・エピジェネティクス診断のカナダ市場規模推移
・エピジェネティクス診断のメキシコ市場規模推移
・エピジェネティクス診断のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等）
・エピジェネティクス診断のドイツ市場規模推移
・エピジェネティクス診断のイギリス市場規模推移
・エピジェネティクス診断のロシア市場規模推移
・エピジェネティクス診断のアジア太平洋市場分析（日本、中国、韓国、インド、東南アジア等）
・エピジェネティクス診断の日本市場規模推移
・エピジェネティクス診断の中国市場規模推移
・エピジェネティクス診断の韓国市場規模推移
・エピジェネティクス診断のインド市場規模推移
・エピジェネティクス診断の東南アジア市場規模推移
・エピジェネティクス診断の南米市場分析（ブラジル、アルゼンチン等）
・エピジェネティクス診断の中東・アフリカ市場分析（サウジアラビア、UAE、南アフリカ等）
・エピジェネティクス診断の種類別分析/販売量、売上、市場シェア（試薬、キット、機器、酵素、サービス）
・エピジェネティクス診断の用途別分析/市場規模（オンコログ、非腫瘍学）
・エピジェネティクス診断の市場予測2019年-2024年（地域別予測、種類別予測、用途別予測）
・エピジェネティクス診断の販売チャネル・代理店・貿易業者・ディーラー分析

【レポートの概要】

Scope of the Report:
The global Epigenetics Diagnostic market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Epigenetics Diagnostic.
Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
This report studies the Epigenetics Diagnostic market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Epigenetics Diagnostic market by product type and applications/end industries.

Market Segment by Companies, this report covers
Qiagen
Abcam plc
Novartis AG
Thermo Fisher Scientific, Inc.
Roche Diagnostics
Eisai Co. Ltd.
Active Motif
Merck
Illumina, Inc.
Diagenode Diagnostics
Zymo Research Corporation
CellCentric
Valirx

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Reagents
Kits
Instruments
Enzymes
Services

Market Segment by Applications, can be divided into
Oncolog
Non-oncology

【レポートの目次】

Table of Contents

1 Epigenetics Diagnostic Market Overview
1.1 Product Overview and Scope of Epigenetics Diagnostic
1.2 Classification of Epigenetics Diagnostic by Types
1.2.1 Global Epigenetics Diagnostic Revenue Comparison by Types (2019-2024)
1.2.2 Global Epigenetics Diagnostic Revenue Market Share by Types in 2018
1.2.3 Reagents
1.2.4 Kits
1.2.5 Instruments
1.2.6 Enzymes
1.2.7 Services
1.3 Global Epigenetics Diagnostic Market by Application
1.3.1 Global Epigenetics Diagnostic Market Size and Market Share Comparison by Applications (2014-2024)
1.3.2 Oncolog
1.3.3 Non-oncology
1.4 Global Epigenetics Diagnostic Market by Regions
1.4.1 Global Epigenetics Diagnostic Market Size (Million USD) Comparison by Regions (2014-2024)
1.4.1 North America (USA, Canada and Mexico) Epigenetics Diagnostic Status and Prospect (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Epigenetics Diagnostic Status and Prospect (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Epigenetics Diagnostic Status and Prospect (2014-2024)
1.4.4 South America (Brazil, Argentina, Colombia) Epigenetics Diagnostic Status and Prospect (2014-2024)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Epigenetics Diagnostic Status and Prospect (2014-2024)
1.5 Global Market Size of Epigenetics Diagnostic (2014-2024)
2 Company Profiles
2.1 Qiagen
2.1.1 Business Overview
2.1.2 Epigenetics Diagnostic Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Qiagen Epigenetics Diagnostic Revenue, Gross Margin and Market Share (2017-2018)
2.2 Abcam plc
2.2.1 Business Overview
2.2.2 Epigenetics Diagnostic Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Abcam plc Epigenetics Diagnostic Revenue, Gross Margin and Market Share (2017-2018)
2.3 Novartis AG
2.3.1 Business Overview
2.3.2 Epigenetics Diagnostic Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Novartis AG Epigenetics Diagnostic Revenue, Gross Margin and Market Share (2017-2018)
2.4 Thermo Fisher Scientific, Inc.
2.4.1 Business Overview
2.4.2 Epigenetics Diagnostic Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Thermo Fisher Scientific, Inc. Epigenetics Diagnostic Revenue, Gross Margin and Market Share (2017-2018)
2.5 Roche Diagnostics
2.5.1 Business Overview
2.5.2 Epigenetics Diagnostic Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Roche Diagnostics Epigenetics Diagnostic Revenue, Gross Margin and Market Share (2017-2018)
2.6 Eisai Co. Ltd.
2.6.1 Business Overview
2.6.2 Epigenetics Diagnostic Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Eisai Co. Ltd. Epigenetics Diagnostic Revenue, Gross Margin and Market Share (2017-2018)
2.7 Active Motif
2.7.1 Business Overview
2.7.2 Epigenetics Diagnostic Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Active Motif Epigenetics Diagnostic Revenue, Gross Margin and Market Share (2017-2018)
2.8 Merck
2.8.1 Business Overview
2.8.2 Epigenetics Diagnostic Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Merck Epigenetics Diagnostic Revenue, Gross Margin and Market Share (2017-2018)
2.9 Illumina, Inc.
2.9.1 Business Overview
2.9.2 Epigenetics Diagnostic Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Illumina, Inc. Epigenetics Diagnostic Revenue, Gross Margin and Market Share (2017-2018)
2.10 Diagenode Diagnostics
2.10.1 Business Overview
2.10.2 Epigenetics Diagnostic Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Diagenode Diagnostics Epigenetics Diagnostic Revenue, Gross Margin and Market Share (2017-2018)
2.11 Zymo Research Corporation
2.11.1 Business Overview
2.11.2 Epigenetics Diagnostic Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Zymo Research Corporation Epigenetics Diagnostic Revenue, Gross Margin and Market Share (2017-2018)
2.12 CellCentric
2.12.1 Business Overview
2.12.2 Epigenetics Diagnostic Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 CellCentric Epigenetics Diagnostic Revenue, Gross Margin and Market Share (2017-2018)
2.13 Valirx
2.13.1 Business Overview
2.13.2 Epigenetics Diagnostic Type and Applications
2.13.2.1 Product A
2.13.2.2 Product B
2.13.3 Valirx Epigenetics Diagnostic Revenue, Gross Margin and Market Share (2017-2018)
3 Global Epigenetics Diagnostic Market Competition, by Players
3.1 Global Epigenetics Diagnostic Revenue and Share by Players (2014-2019)
3.2 Market Concentration Rate
3.2.1 Top 5 Epigenetics Diagnostic Players Market Share
3.2.2 Top 10 Epigenetics Diagnostic Players Market Share
3.3 Market Competition Trend
4 Global Epigenetics Diagnostic Market Size by Regions
4.1 Global Epigenetics Diagnostic Revenue and Market Share by Regions
4.2 North America Epigenetics Diagnostic Revenue and Growth Rate (2014-2019)
4.3 Europe Epigenetics Diagnostic Revenue and Growth Rate (2014-2019)
4.4 Asia-Pacific Epigenetics Diagnostic Revenue and Growth Rate (2014-2019)
4.5 South America Epigenetics Diagnostic Revenue and Growth Rate (2014-2019)
4.6 Middle East and Africa Epigenetics Diagnostic Revenue and Growth Rate (2014-2019)
5 North America Epigenetics Diagnostic Revenue by Countries
5.1 North America Epigenetics Diagnostic Revenue by Countries (2014-2019)
5.2 USA Epigenetics Diagnostic Revenue and Growth Rate (2014-2019)
5.3 Canada Epigenetics Diagnostic Revenue and Growth Rate (2014-2019)
5.4 Mexico Epigenetics Diagnostic Revenue and Growth Rate (2014-2019)
6 Europe Epigenetics Diagnostic Revenue by Countries
6.1 Europe Epigenetics Diagnostic Revenue by Countries (2014-2019)
6.2 Germany Epigenetics Diagnostic Revenue and Growth Rate (2014-2019)
6.3 UK Epigenetics Diagnostic Revenue and Growth Rate (2014-2019)
6.4 France Epigenetics Diagnostic Revenue and Growth Rate (2014-2019)
6.5 Russia Epigenetics Diagnostic Revenue and Growth Rate (2014-2019)
6.6 Italy Epigenetics Diagnostic Revenue and Growth Rate (2014-2019)
7 Asia-Pacific Epigenetics Diagnostic Revenue by Countries
7.1 Asia-Pacific Epigenetics Diagnostic Revenue by Countries (2014-2019)
7.2 China Epigenetics Diagnostic Revenue and Growth Rate (2014-2019)
7.3 Japan Epigenetics Diagnostic Revenue and Growth Rate (2014-2019)
7.4 Korea Epigenetics Diagnostic Revenue and Growth Rate (2014-2019)
7.5 India Epigenetics Diagnostic Revenue and Growth Rate (2014-2019)
7.6 Southeast Asia Epigenetics Diagnostic Revenue and Growth Rate (2014-2019)
8 South America Epigenetics Diagnostic Revenue by Countries
8.1 South America Epigenetics Diagnostic Revenue by Countries (2014-2019)
8.2 Brazil Epigenetics Diagnostic Revenue and Growth Rate (2014-2019)
8.3 Argentina Epigenetics Diagnostic Revenue and Growth Rate (2014-2019)
8.4 Colombia Epigenetics Diagnostic Revenue and Growth Rate (2014-2019)
9 Middle East and Africa Revenue Epigenetics Diagnostic by Countries
9.1 Middle East and Africa Epigenetics Diagnostic Revenue by Countries (2014-2019)
9.2 Saudi Arabia Epigenetics Diagnostic Revenue and Growth Rate (2014-2019)
9.3 UAE Epigenetics Diagnostic Revenue and Growth Rate (2014-2019)
9.4 Egypt Epigenetics Diagnostic Revenue and Growth Rate (2014-2019)
9.5 Nigeria Epigenetics Diagnostic Revenue and Growth Rate (2014-2019)
9.6 South Africa Epigenetics Diagnostic Revenue and Growth Rate (2014-2019)
10 Global Epigenetics Diagnostic Market Segment by Type
10.1 Global Epigenetics Diagnostic Revenue and Market Share by Type (2014-2019)
10.2 Global Epigenetics Diagnostic Market Forecast by Type (2019-2024)
10.3 Reagents Revenue Growth Rate (2014-2024)
10.4 Kits Revenue Growth Rate (2014-2024)
10.5 Instruments Revenue Growth Rate (2014-2024)
10.6 Enzymes Revenue Growth Rate (2014-2024)
10.7 Services Revenue Growth Rate (2014-2024)
11 Global Epigenetics Diagnostic Market Segment by Application
11.1 Global Epigenetics Diagnostic Revenue Market Share by Application (2014-2019)
11.2 Epigenetics Diagnostic Market Forecast by Application (2019-2024)
11.3 Oncolog Revenue Growth (2014-2019)
11.4 Non-oncology Revenue Growth (2014-2019)
12 Global Epigenetics Diagnostic Market Size Forecast (2019-2024)
12.1 Global Epigenetics Diagnostic Market Size Forecast (2019-2024)
12.2 Global Epigenetics Diagnostic Market Forecast by Regions (2019-2024)
12.3 North America Epigenetics Diagnostic Revenue Market Forecast (2019-2024)
12.4 Europe Epigenetics Diagnostic Revenue Market Forecast (2019-2024)
12.5 Asia-Pacific Epigenetics Diagnostic Revenue Market Forecast (2019-2024)
12.6 South America Epigenetics Diagnostic Revenue Market Forecast (2019-2024)
12.7 Middle East and Africa Epigenetics Diagnostic Revenue Market Forecast (2019-2024)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source

List of Tables and Figures

Figure Epigenetics Diagnostic Picture
Table Product Specifications of Epigenetics Diagnostic
Table Global Epigenetics Diagnostic and Revenue (Million USD) Market Split by Product Type
Figure Global Epigenetics Diagnostic Revenue Market Share by Types in 2018
Figure Reagents Picture
Figure Kits Picture
Figure Instruments Picture
Figure Enzymes Picture
Figure Services Picture
Table Global Epigenetics Diagnostic Revenue (Million USD) by Application (2014-2024)
Figure Epigenetics Diagnostic Revenue Market Share by Applications in 2018
Figure Oncolog Picture
Figure Non-oncology Picture
Table Global Market Epigenetics Diagnostic Revenue (Million USD) Comparison by Regions 2014-2024
Figure North America Epigenetics Diagnostic Revenue (Million USD) and Growth Rate (2014-2024)
Figure Europe Epigenetics Diagnostic Revenue (Million USD) and Growth Rate (2014-2024)
Figure Asia-Pacific Epigenetics Diagnostic Revenue (Million USD) and Growth Rate (2014-2024)
Figure South America Epigenetics Diagnostic Revenue (Million USD) and Growth Rate (2014-2024)
Figure Middle East and Africa Epigenetics Diagnostic Revenue (Million USD) and Growth Rate (2014-2024)
Figure Global Epigenetics Diagnostic Revenue (Million USD) and Growth Rate (2014-2024)
Table Qiagen Basic Information, Manufacturing Base and Competitors
Table Qiagen Epigenetics Diagnostic Type and Applications
Table Qiagen Epigenetics Diagnostic Revenue, Gross Margin and Market Share (2017-2018)
Table Abcam plc Basic Information, Manufacturing Base and Competitors
Table Abcam plc Epigenetics Diagnostic Type and Applications
Table Abcam plc Epigenetics Diagnostic Revenue, Gross Margin and Market Share (2017-2018)
Table Novartis AG Basic Information, Manufacturing Base and Competitors
Table Novartis AG Epigenetics Diagnostic Type and Applications
Table Novartis AG Epigenetics Diagnostic Revenue, Gross Margin and Market Share (2017-2018)
Table Thermo Fisher Scientific, Inc. Basic Information, Manufacturing Base and Competitors
Table Thermo Fisher Scientific, Inc. Epigenetics Diagnostic Type and Applications
Table Thermo Fisher Scientific, Inc. Epigenetics Diagnostic Revenue, Gross Margin and Market Share (2017-2018)
Table Roche Diagnostics Basic Information, Manufacturing Base and Competitors
Table Roche Diagnostics Epigenetics Diagnostic Type and Applications
Table Roche Diagnostics Epigenetics Diagnostic Revenue, Gross Margin and Market Share (2017-2018)
Table Eisai Co. Ltd. Basic Information, Manufacturing Base and Competitors
Table Eisai Co. Ltd. Epigenetics Diagnostic Type and Applications
Table Eisai Co. Ltd. Epigenetics Diagnostic Revenue, Gross Margin and Market Share (2017-2018)
Table Active Motif Basic Information, Manufacturing Base and Competitors
Table Active Motif Epigenetics Diagnostic Type and Applications
Table Active Motif Epigenetics Diagnostic Revenue, Gross Margin and Market Share (2017-2018)
Table Merck Basic Information, Manufacturing Base and Competitors
Table Merck Epigenetics Diagnostic Type and Applications
Table Merck Epigenetics Diagnostic Revenue, Gross Margin and Market Share (2017-2018)
Table Illumina, Inc. Basic Information, Manufacturing Base and Competitors
Table Illumina, Inc. Epigenetics Diagnostic Type and Applications
Table Illumina, Inc. Epigenetics Diagnostic Revenue, Gross Margin and Market Share (2017-2018)
Table Diagenode Diagnostics Basic Information, Manufacturing Base and Competitors
Table Diagenode Diagnostics Epigenetics Diagnostic Type and Applications
Table Diagenode Diagnostics Epigenetics Diagnostic Revenue, Gross Margin and Market Share (2017-2018)
Table Zymo Research Corporation Basic Information, Manufacturing Base and Competitors
Table Zymo Research Corporation Epigenetics Diagnostic Type and Applications
Table Zymo Research Corporation Epigenetics Diagnostic Revenue, Gross Margin and Market Share (2017-2018)
Table CellCentric Basic Information, Manufacturing Base and Competitors
Table CellCentric Epigenetics Diagnostic Type and Applications
Table CellCentric Epigenetics Diagnostic Revenue, Gross Margin and Market Share (2017-2018)
Table Valirx Basic Information, Manufacturing Base and Competitors
Table Valirx Epigenetics Diagnostic Type and Applications
Table Valirx Epigenetics Diagnostic Revenue, Gross Margin and Market Share (2017-2018)
Table Global Epigenetics Diagnostic Revenue (Million USD) by Players (2014-2019)
Table Global Epigenetics Diagnostic Revenue Share by Players (2014-2019)
Figure Global Epigenetics Diagnostic Revenue Share by Players in 2017
Figure Global Epigenetics Diagnostic Revenue Share by Players in 2018
Figure Global Top 5 Players Epigenetics Diagnostic Revenue Market Share in 2018
Figure Global Top 10 Players Epigenetics Diagnostic Revenue Market Share in 2018
Figure Global Epigenetics Diagnostic Revenue (Million USD) and Growth Rate (%) (2014-2019)
Table Global Epigenetics Diagnostic Revenue (Million USD) by Regions (2014-2019)
Table Global Epigenetics Diagnostic Revenue Market Share by Regions (2014-2019)
Figure Global Epigenetics Diagnostic Revenue Market Share by Regions (2014-2019)
Figure Global Epigenetics Diagnostic Revenue Market Share by Regions in 2018
Figure North America Epigenetics Diagnostic Revenue and Growth Rate (2014-2019)
Figure Europe Epigenetics Diagnostic Revenue and Growth Rate (2014-2019)
Figure Asia-Pacific Epigenetics Diagnostic Revenue and Growth Rate (2014-2019)
Figure South America Epigenetics Diagnostic Revenue and Growth Rate (2014-2019)
Figure Middle East and Africa Epigenetics Diagnostic Revenue and Growth Rate (2014-2019)
Table North America Epigenetics Diagnostic Revenue by Countries (2014-2019)
Table North America Epigenetics Diagnostic Revenue Market Share by Countries (2014-2019)
Figure North America Epigenetics Diagnostic Revenue Market Share by Countries (2014-2019)
Figure North America Epigenetics Diagnostic Revenue Market Share by Countries in 2018
Figure USA Epigenetics Diagnostic Revenue and Growth Rate (2014-2019)
Figure Canada Epigenetics Diagnostic Revenue and Growth Rate (2014-2019)
Figure Mexico Epigenetics Diagnostic Revenue and Growth Rate (2014-2019)
Table Europe Epigenetics Diagnostic Revenue (Million USD) by Countries (2014-2019)
Figure Europe Epigenetics Diagnostic Revenue Market Share by Countries (2014-2019)
Figure Europe Epigenetics Diagnostic Revenue Market Share by Countries in 2018
Figure Germany Epigenetics Diagnostic Revenue and Growth Rate (2014-2019)
Figure UK Epigenetics Diagnostic Revenue and Growth Rate (2014-2019)
Figure France Epigenetics Diagnostic Revenue and Growth Rate (2014-2019)
Figure Russia Epigenetics Diagnostic Revenue and Growth Rate (2014-2019)
Figure Italy Epigenetics Diagnostic Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Epigenetics Diagnostic Revenue (Million USD) by Countries (2014-2019)
Figure Asia-Pacific Epigenetics Diagnostic Revenue Market Share by Countries (2014-2019)
Figure Asia-Pacific Epigenetics Diagnostic Revenue Market Share by Countries in 2018
Figure China Epigenetics Diagnostic Revenue and Growth Rate (2014-2019)
Figure Japan Epigenetics Diagnostic Revenue and Growth Rate (2014-2019)
Figure Korea Epigenetics Diagnostic Revenue and Growth Rate (2014-2019)
Figure India Epigenetics Diagnostic Revenue and Growth Rate (2014-2019)
Figure Southeast Asia Epigenetics Diagnostic Revenue and Growth Rate (2014-2019)
Table South America Epigenetics Diagnostic Revenue by Countries (2014-2019)
Table South America Epigenetics Diagnostic Revenue Market Share by Countries (2014-2019)
Figure South America Epigenetics Diagnostic Revenue Market Share by Countries (2014-2019)
Figure South America Epigenetics Diagnostic Revenue Market Share by Countries in 2018
Figure Brazil Epigenetics Diagnostic Revenue and Growth Rate (2014-2019)
Figure Argentina Epigenetics Diagnostic Revenue and Growth Rate (2014-2019)
Figure Colombia Epigenetics Diagnostic Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Epigenetics Diagnostic Revenue (Million USD) by Countries (2014-2019)
Table Middle East and Africa Epigenetics Diagnostic Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Epigenetics Diagnostic Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Epigenetics Diagnostic Revenue Market Share by Countries in 2018
Figure Saudi Arabia Epigenetics Diagnostic Revenue and Growth Rate (2014-2019)
Figure UAE Epigenetics Diagnostic Revenue and Growth Rate (2014-2019)
Figure Egypt Epigenetics Diagnostic Revenue and Growth Rate (2014-2019)
Figure Nigeria Epigenetics Diagnostic Revenue and Growth Rate (2014-2019)
Figure South Africa Epigenetics Diagnostic Revenue and Growth Rate (2014-2019)
Table Global Epigenetics Diagnostic Revenue (Million USD) by Type (2014-2019)
Table Global Epigenetics Diagnostic Revenue Share by Type (2014-2019)
Figure Global Epigenetics Diagnostic Revenue Share by Type (2014-2019)
Figure Global Epigenetics Diagnostic Revenue Share by Type in 2018
Table Global Epigenetics Diagnostic Revenue Forecast by Type (2019-2024)
Figure Global Epigenetics Diagnostic Market Share Forecast by Type (2019-2024)
Figure Global Reagents Revenue Growth Rate (2014-2019)
Figure Global Kits Revenue Growth Rate (2014-2019)
Figure Global Instruments Revenue Growth Rate (2014-2019)
Figure Global Enzymes Revenue Growth Rate (2014-2019)
Figure Global Services Revenue Growth Rate (2014-2019)
Table Global Epigenetics Diagnostic Revenue by Application (2014-2019)
Table Global Epigenetics Diagnostic Revenue Share by Application (2014-2019)
Figure Global Epigenetics Diagnostic Revenue Share by Application (2014-2019)
Figure Global Epigenetics Diagnostic Revenue Share by Application in 2018
Table Global Epigenetics Diagnostic Revenue Forecast by Application (2019-2024)
Figure Global Epigenetics Diagnostic Market Share Forecast by Application (2019-2024)
Figure Global Oncolog Revenue Growth Rate (2014-2019)
Figure Global Non-oncology Revenue Growth Rate (2014-2019)
Figure Global Epigenetics Diagnostic Revenue (Million USD) and Growth Rate Forecast (2019-2024)
Table Global Epigenetics Diagnostic Revenue (Million USD) Forecast by Regions (2019-2024)
Figure Global Epigenetics Diagnostic Revenue Market Share Forecast by Regions (2019-2024)
Figure North America Epigenetics Diagnostic Revenue Market Forecast (2019-2024)
Figure Europe Epigenetics Diagnostic Revenue Market Forecast (2019-2024)
Figure Asia-Pacific Epigenetics Diagnostic Revenue Market Forecast (2019-2024)
Figure South America Epigenetics Diagnostic Revenue Market Forecast (2019-2024)
Figure Middle East and Africa Epigenetics Diagnostic Revenue Market Forecast (2019-2024)

【掲載企業】

Qiagen、 Abcam plc、 Novartis AG、 Thermo Fisher Scientific, Inc.、 Roche Diagnostics、 Eisai Co. Ltd.、 Active Motif、 Merck、 Illumina, Inc.、 Diagenode Diagnostics、 Zymo Research Corporation、 CellCentric、 Valirx

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ エピジェネティクス診断の世界市場2019(Global Epigenetics Diagnostic Market 2019 by Company, Regions, Type and Application, Forecast to 2024)]についてメールでお問い合わせはこちらでお願いします。

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 GlobalResearch.jp